Duloxetine Hydrochloride CAS: 136434-34-9

CAS NO: 136434-34-9
Duloxetine Hydrochloride
Chemical Name: Duloxetine hydrochloride
Molecular Formula: C18H20ClNOS
Formula Weight: 333.88
CAS No.: 136434-34-9
Description Review
Description

Duloxetine Hydrochloride, also known as Cymbalta, is a medication used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and chronic pain. It belongs to the class of drugs called selective serotonin and norepinephrine reuptake inhibitors (SNRIs), which work by increasing the levels of these neurotransmitters in the brain.

Chemical Name:

The chemical name of Duloxetine Hydrochloride is (+)-(S)-N-Methyl-3-(1-naphthyloxy)-2-thiophenepropanamine hydrochloride.

Molecular Formula:

The molecular formula of Duloxetine Hydrochloride is C18H20ClNOS.

Formula Weight:

The formula weight of Duloxetine Hydrochloride is 333.88 g/mol.

CAS No:

The CAS number of Duloxetine Hydrochloride is 136434-34-9.

Top Ten Keywords from Google and Synonyms:

  1. SNRI medication
  2. Major depressive disorder treatment
  3. Generalized anxiety disorder drug
  4. Fibromyalgia therapy
  5. Chronic pain management
  6. Cymbalta
  7. Dual reuptake inhibitor
  8. Antidepressant medication
  9. Neurotransmitter modulator
  10. Psychiatric medication

Synonyms: Duloxetine, Duloxetine HCl, Ariclaim, Duzela, Yentreve

Health Benefits of Duloxetine Hydrochloride:

Duloxetine Hydrochloride is primarily used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and chronic pain. It helps in reducing symptoms such as low mood, loss of interest, anxiety, and pain. Additionally, it can improve energy level and quality of life in some patients.

Potential Effects:

Duloxetine Hydrochloride is an SNRI that works by increasing the levels of serotonin and norepinephrine in the brain. By doing so, it improves the communication between neurons and enhances mood, reduces anxiety, and alleviates pain. It also has a sedative effect, which can help patients sleep better.

Product Mechanism:

Duloxetine Hydrochloride works by inhibiting the reuptake of serotonin and norepinephrine in the brain. These neurotransmitters are responsible for regulating mood, anxiety, and pain perception. By blocking their reuptake, Duloxetine Hydrochloride increases their availability in the synaptic cleft, which enhances their effects and leads to improved mood, reduced anxiety, and pain relief.

Safety:

Duloxetine Hydrochloride is generally considered safe when used as directed. However, like all medications, it may cause side effects in some people. It is not recommended for certain patients, such as those who have liver disease, severe renal impairment, or a history of suicidal ideation. It should also be used with caution in people with glaucoma, bipolar disorder, or a bleeding disorder.

Side Effects:

Common side effects of Duloxetine Hydrochloride include nausea, dry mouth, constipation, and insomnia. Rare but serious side effects may include serotonin syndrome, hyponatremia, and hepatotoxicity. Patients who experience any of these symptoms should seek immediate medical attention.

Dosing Information:

The recommended dose of Duloxetine Hydrochloride depends on the condition being treated and the individual patient's response to the medication. For major depressive disorder, the usual starting dose is 60 mg once daily, which may be increased gradually to a maximum of 120 mg per day. For generalized anxiety disorder, the recommended starting dose is 30 mg once daily, which may be increased gradually to a maximum of 120 mg per day. For fibromyalgia and chronic pain, the usual dose is 60 mg once daily, and may be increased to 120 mg per day if needed.

Conclusion:

Duloxetine Hydrochloride is an SNRI medication used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, and chronic pain. It works by increasing the levels of serotonin and norepinephrine in the brain, which can improve mood, reduce anxiety, and alleviate pain. While it is generally safe and effective, it may cause side effects in some patients and is not recommended for certain populations. If you have any questions about Duloxetine Hydrochloride or its use, please consult your healthcare provider

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code